- $4.98m
- $12.43m
- $1.73m
Brief: VolitionRX Ltd Announces Pricing Of $6 Million Underwritten Public Offering Of Common Stock
Brief: Volitionrx Limited Announces Proposed Underwritten Public Offering Of Common Stock
Brief: VolitionRX Entered Into Equity Distribution Agreement With Jefferies LLC
Brief: Volition Signs Exclusive $28 Million License, Supply Deal With Heska
Brief: Heska Says Volition To Get $10 Million Upfront Payment, Up To $18 Million Based Upon Achievement Of Near/Mid-Term Milestones
Brief: Volitionrx Ltd Posts Q3 Net Loss Of $7.2 Million
Brief: VolitionRX Files For Mixed Shelf Of Up To $100 Mln
Brief: VolitionRX Ltd Q2 Posts Net Loss Of $5.6 Million
VolitionRx plunges on $20 mln stock deal
Brief: VolitionRx Limited Announces Pricing Of $20 Million Underwritten Public Offering Of Common Stock
Expects To Report That It Had Approximately $19.4 Million In Cash And Cash Equivalents As Of December 31, 2020
Brief: VolitionRx Limited Announces Proposed Underwritten Public Offering Of Common Stock
Brief: VolitionRx Ltd Announces Appointment Of A New CFO, Terig Hughes
Brief: Volitionrx Limited Awarded An Additional $4 Million In Non-Dilutive Funding
Brief: Volitionrx Ltd Set Size Of Board At Seven Members
Brief: VolitionRx Reports Q3 2020 Results
AMEX HALT EQUIPMENT CHANGEOVER LAST 2.92000
Brief: Volition Announces Promising Clinical Trials Results For Its Novel COVID-19 Triage Test
Brief: Cotterford Co. Ltd. Sends Letter To VolitionRX Following Annual Meeting Vote